Contineum Therapeutics, Inc.
CTNM
$9.80
-$0.59-5.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -19.74% | 61.75% | 63.56% | 58.31% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -18.72% | -21.06% | -35.29% | -48.75% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -19.74% | 60.50% | 61.61% | 56.43% | -- |
|
|
|||||
| Total Current Assets | -19.74% | 60.50% | 61.61% | 56.43% | -- |
| Net Property, Plant & Equipment | 468.12% | 398.05% | 362.13% | -34.75% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6,100.00% | -99.85% | -99.77% | -98.06% | -- |
| Total Assets | -17.38% | 60.45% | 63.24% | 55.37% | -- |
|
|
|||||
| Total Accounts Payable | 172.62% | 539.47% | 185.20% | 32.54% | -- |
| Total Accrued Expenses | 48.63% | -25.84% | 53.04% | -17.16% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 202.89% | 206.96% | 212.93% | -45.50% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 92.94% | 43.55% | 81.87% | -21.92% | -- |
|
|
|||||
| Total Current Liabilities | 92.94% | 43.55% | 81.87% | -21.92% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3,691.15% | 3,996.40% | 4,350.93% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 198.49% | 105.32% | 159.22% | -23.29% | -- |
|
|
|||||
| Common Stock & APIC | 3.38% | 3,879.85% | 4,342.21% | 4,844.68% | -- |
| Retained Earnings | -61.43% | -59.63% | -56.24% | -52.63% | -- |
| Treasury Stock & Other | 215.75% | 393.10% | -34.26% | 730.34% | -- |
| Total Common Equity | -21.20% | 344.31% | 391.55% | 443.82% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.20% | 344.31% | 391.55% | 443.82% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.20% | 57.93% | 58.85% | 59.90% | -- |
|
|
|||||